Learn more

NAT UNIV CORP TOTTORI UNIV

Overview
  • Total Patents
    177
  • GoodIP Patent Rank
    14,131
  • Filing trend
    ⇩ 40.0%
About

NAT UNIV CORP TOTTORI UNIV has a total of 177 patent applications. It decreased the IP activity by 40.0%. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are LAYTON BIOSCIENCE INC, BAMBOO THERAPEUTICS INC and JIKEI UNIVERSITY SCHOOL OF MED.

Patent filings per year

Chart showing NAT UNIV CORP TOTTORI UNIVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Oshimura Mitsuo 33
#2 Kazuki Yasuhiro 30
#3 Shiota Goshi 19
#4 Nakamura Takafumi 16
#5 Miura Norimasa 16
#6 Itaba Noriko 15
#7 Morimoto Minoru 12
#8 Kouno Yohei 10
#9 Oka Hiroyuki 10
#10 Shimizu Hiroki 10

Latest patents

Publication Filing date Title
WO2021075418A1 Image processing method, teacher data generation method, trained model generation method, illness development prediction method, image processing device, image processing program, and recording medium on which program is recorded
WO2021054474A1 Repeating disaccharide for oligosaccharide synthesis and method for producing oligomer thereof
WO2021039988A1 Conductive-bridge memory device, method for manufacturing same, and switch device
WO2020230785A1 Cell fusion-inducing vaccinia virus and use thereof
US2021123027A1 Method for producing human induced pluripotent stem cells containing exogenous chromosome
WO2020075823A1 Method for producing animal cell containing dna of interest using micronucleate cell fusion method
SG11202012191YA Conductive bridge memory device, manufacturing method thereof, and switching element
WO2019177163A1 Mouse artificial chromosome vector and use thereof
WO2019088257A1 High-yield production method for protein by using mammalian artificial chromosome vector
TW201912780A Cell layer with fibrosis inhibition
WO2018079857A1 Human antibody–producing non-human animal and method for preparing human antibodies using same
EP3520609A1 Down syndrome model rat and method for producing same
WO2018012570A1 Method for producing vaccinia virus expressing foreign gene
WO2017222029A1 Method for producing fermented milk having high angiotensin converting enzyme inhibition activity, and method for producing physiologically active peptide
CN109069490A Antidementia agent or preventive medicine
WO2017073692A1 Inhibitors for methylation-related enzymes hat1 and kat8
WO2017073689A1 Rna molecule for repairing dna damage
EP3366687A1 Suppression and regeneration promoting effect of low molecular weight compound on cancer and fibrosis
EP3327137A1 Host regulation factor for enhancing proliferation and propagation of vaccinia virus
AU2016294185A1 Estrogen receptor ß partial agonist having estrogen receptor a inhibitory effect, and therapeutic agent for gynecological disorders using same